Edelson RL. Extracorporeal photopheresis. Photodermatol. 1984;1(5):209–10.

CAS  PubMed  Google Scholar 

Knobler R, Berlin G, Calzavara-Pinton P, Greinix H, Jaksch P, Laroche L, et al. Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol. 2014;28(Suppl 1Suppl 1):1–37.

Article  CAS  PubMed  Google Scholar 

Latzka J, Assaf C, Bagot M, Cozzio A, Dummer R, Guenova E, et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome –update 2023. Eur J Cancer. 2023. https://doi.org/10.1016/j.ejca.2023.113343.

Article  PubMed  Google Scholar 

National coverage determination (NCD). for extracorporeal photopheresis (110.4). Baltimore, MD: Centers for Medicare & Medicaid Services; [updated 2006 Aug 4. Available from: https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=113

National Comprehensive Cancer Network. 2025. NCCN clinical practice guidelines in oncology: primary cutaneous lymphomas. Version 3.2025. 2025. [online] Available at: https://NCCN.org. Accessed 1 Jul 2025.

Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, et al. Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the writing committee of the American society for apheresis: the sixth special issue. J Clin Apher. 2013;28(3):145–284.

Article  PubMed  Google Scholar 

Dignan FL, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P, et al. Diagnosis and management of acute graft-versus-host disease. Br J Haematol. 2012;158(1):30–45.

Article  CAS  PubMed  Google Scholar 

Dignan FL, Amrolia P, Clark A, Cornish J, Jackson G, Mahendra P, et al. Diagnosis and management of chronic graft-versus-host disease. Br J Haematol. 2012;158(1):46–61.

Vascular access for extracorporeal photopheresis. Raritan (NJ). Therakos (Mallinckrodt Pharmaceuticals); [cited 2025 July 7]. Available from: https://therakoshcp.ca/assets/PDF/CA%20%20Vascular%20Access%20Brochure%20Therakos%20(CA-2000096).pdf

Bojanic I, Worel N, Pacini CP, Stary G, Piekarska A, Flinn AM, et al. Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers. Front Immunol. 2023;14:1086006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wolff D, Schleuning M, von Harsdorf S, Bacher U, Gerbitz A, Stadler M, et al. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2011;17(1):1–17.

Article  PubMed  Google Scholar 

Liszewski W, Omland SH, Gniadecki R. The successful use of extracorporeal photopheresis in a 12-year-old patient with refractory epidermolysis bullosa acquisita. Pediatr Dermatol. 2015;32(2):e60–1.

Article  PubMed  Google Scholar 

Vonderheid EC, Kang CA, Kadin M, Bigler RD, Griffin TD, Rogers TJ. Extracorporeal photopheresis in psoriasis vulgaris: clinical and immunologic observations. J Am Acad Dermatol. 1990;23(4 Pt 1):703–12.

Article  CAS  PubMed  Google Scholar 

Klassen J. The role of photopheresis in the treatment of graft-versus-host disease. Curr Oncol. 2010;17(2):55–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malawista SE, Trock DH, Edelson RL. Treatment of rheumatoid arthritis by extracorporeal photochemotherapy. A pilot study. Arthritis Rheum. 1991;34(6):646–54.

Article  CAS  PubMed  Google Scholar 

Dunbar NM, Raval JS, Johnson A, Abikoff CM, Adamski J, Cooling LL, et al. Extracorporeal photopheresis practice patterns: an international survey by the ASFA ECP subcommittee. J Clin Apher. 2017;32(4):215–23.

Article  PubMed  Google Scholar 

Wolnicka-Glubisz A, Fraczek J, Skrzeczynska-Moncznik J, Friedlein G, Mikolajczyk T, Sarna T, Wojewoda K, Gillstedt M, Lewerin C, Osmancevicet al. Effect of UVA and 8-methoxypsoralen, 4, 6, 4’-trimethylangelicin or chlorpromazine on apoptosis of lymphocytes and their recognition by monocytes. J Physiol Pharmacol. 2010;61(1):107–14.

CAS  PubMed  Google Scholar 

Whittle R, Taylor PC. Circulating b-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis. Blood. 2011;118(24):6446–9.

Article  CAS  PubMed  Google Scholar 

Asensi Cantó P, Sanz Caballer J, Solves Alcaína P, de la Rubia Comos J, Gómez Seguí I. Extracorporeal photopheresis in Graft-versus-Host disease. Transplant Cell Ther. 2023;29(9):556–66.

Article  PubMed  Google Scholar 

UVADEX. (methoxsalen) Sterile solution [prescribing information]. Therakos LLC. 2013.

Cho A, Jantschitsch C, Knobler R. Extracorporeal Photopheresis—An Overview. Front Med. 2018;Volume 5–2018.

Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American society for apheresis: the eighth special issue. J Clin Apher. 2019;34(3):171–354.

Article  PubMed  Google Scholar 

Matsumura Y, Ananthaswamy HN. Short-term and long-term cellular and molecular events following UV irradiation of skin: implications for molecular medicine. Expert Rev Mol Med. 2002;4(26):1–22.

Article  PubMed  Google Scholar 

Knobler RM, Trautinger F, Graninger W, Macheiner W, Gruenwald C, Neumann R, et al. Parenteral administration of 8-methoxypsoralen in photopheresis. J Am Acad Dermatol. 1993;28(4):580–4.

Article  CAS  PubMed  Google Scholar 

THERAKOS® CELLEX®. Photopheresis System: Operator’s Manual. Therakos, Inc; 2014.

Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med. 1987;316(6):297.

Article  CAS  PubMed  Google Scholar 

Scarisbrick J. Extracorporeal photopheresis: what is it and when should it be used? Clin Exp Dermatol. 2009;34(7):757–60.

Article  CAS  PubMed  Google Scholar 

Quaglino P, Knobler R, Fierro MT, Savoia P, Marra E, Fava P, et al. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature. Int J Dermatol. 2013;52(11):1308–18.

Article  CAS  PubMed  Google Scholar 

Alfred A, Taylor PC, Dignan F, El-Ghariani K, Griffin J, Gennery AR, et al. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK photopheresis society. Br J Haematol. 2017;177(2):287–310.

Article  PubMed  PubMed Central  Google Scholar 

FDA Examining Patient Deaths Associated With Extracorporeal Photopheresis. Treatment American Society of Hematology 2018 Accessed 4 Dec 2025. Available from: https://ashpublications.org/ashclinicalnews/news/3778/FDA-Examining-Patient-Deaths-Associated-With

Jacobs JW, Adkins BD, Bibb LA, Woo JS, Allen ES, Stephens LD, et al. The potential association between extracorporeal photopheresis and thrombosis. Bone Marrow Transplant. 2024;59(2):270–3.

Article  PubMed  Google Scholar 

Gambichler T, Chatzipantazi M, Stranzenbach R, Feldkamp A, Susok L. Impact of extracorporeal photopheresis on blood and coagulation parameters. Dermatol Ther. 2022;35(5):e15366.

Article  CAS  PubMed  Google Scholar 

Gonzalez AL, Berger CL, Remington J, Girardi M, Tigelaar RE, Edelson RL. Integrin-driven monocyte to dendritic cell conversion in modified extracorporeal photochemotherapy. Clin Exp Immunol. 2014;175(3):449–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou XA, Choi J. Photopheresis: advances and use in systemic sclerosis. Curr Rheumatol Rep. 2017;19(6):31.

Article  PubMed  Google Scholar 

Tatsuno K, Yamazaki T, Hanlon D, Han P, Robinson E, Sobolev O, et al. Extracorporeal photochemotherapy induces bona fide immunogenic cell death. Cell Death Dis. 2019;10(8):578.

Article  PubMed  PubMed Central  Google Scholar 

Tsai YC, Schlaepfer T, Ignatova D, Chang YT, Valaperti A, Amarov B, et al. Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma. Br J Dermatol. 2023;189(5):603–11.

Article  CAS  PubMed  Google Scholar 

Schneiderman J, Qiu L, Yeap XY, Kang X, Zheng F, Ye J, et al. Pre-transplant infusion of donor leukocytes treated with extracorporeal photochemotherapy induces immune hypo-responsiveness and long-term allograft survival in murine models. Sci Rep. 2022;12(1):7298.

Article  CAS  PubMed  PubMed Central  Google Scholar